Molecular characteristics of equine stromelysin and the tissue inhibitor of metalloproteinase

American Journal of Veterinary Research

Volumn 59, Issue 12, 1998, Pages 1557-1562

  Richardson, Dean W ^a   Dodge, George R ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; RECOMBINANT PROTEIN; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; ARTICULAR CARTILAGE; BIOSYNTHESIS; CHEMISTRY; ENZYMOLOGY; GENE LIBRARY; GENETICS; HORSE; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CARTILAGE, ARTICULAR; CONSERVED SEQUENCE; DNA, COMPLEMENTARY; GENE LIBRARY; HORSES; HUMANS; MATRIX METALLOPROTEINASE 3; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; RNA, MESSENGER; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 0032238551     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Woessner JF Jr. Gunja-Smith Z. Role of metalloproteinases in human osteoarthritis. J Rheumatol 1991;27 (Suppl):99-101.
2. McIlwraith CW, Trotter GW. Joint disease in the horse. 1st ed. Philadelphia: WB Saunders Co, 1996;1-68.
3. Morris EA, Treadwell BV. Effect of interleukin 1 on articular cartilage from young and aged horses and comparison with metabolism of ostcoarthritic cartilage. Am J Vet Res 1994;55:138-146.
4. May SA, Hooke RE, Lees P. Adverse conditions in vitro stimulate chondrocytes to produce prostaglandin E2 and stromelysin. Equine Vet J 1991;23:380-382.
5. Balkman CE, Nixon AJ. Molecular cloning and cartilage gene expression of equine stromelysin 1 (matrix metalloproteinase 3). Am J Vet Res 1998;59:30-36.
6. Hughes C, Murphy G, Hardingham TE. Metalloproteinase digestion of cartilage proteoglycan. Pattern of cleavage by stromelysin and susceptibility to collagenase. Biochem J 1991;279:733-739.
7. Eyre DR. The collagens of articular cartilage. Semin Arthritis Rheum 1991;21:2-11.
8. Eyre DR, Wu JJ, Woods PE. The cartilage collagens: structural and metabolic studies. J Rheumatol Suppl 1991;27:49-51.
9. Kleiner DE Jr, Stetler-Stevenson WG. Structural biochemistry and activation of matrix metalloproteases. Curr Opin Cell Biol 1993;5:891-897.
10. Nagase H. Activation mechanisms of matrix metalloproteinases. Biol Chem 1997;378:151-160.
11. Caron JP, Tardif G, Martel-Pelletier J, et al. Modulation of matrix metalloprotease 13 (collagenase 3) gene expression in equine chondrocytes by interleukin 1 and corticosteroids. Am J Vet Res 1996;57:1631-1634.
12. Clegg PD, Coughlan AR, Riggs CM, et al. Matrix metalloproteinases 2 and 9 in equine synovial fluids Equine Vet J 1997;29: 343-348.
13. Clegg PD, Burke RM, Coughlan AR, et al. Characterisation of equine matrix metalloproteinase 2 and 9; and identification of the cellular sources of these enzymes in joints. Equine Vet J 1997;29: 335-342.
14. Docherty AJ, Lyons A, Smith BJ, et al. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 1985;318:66-69.
15. Dean DD, Woessner JE Jr. Extracts of human articular cartilage contain an inhibitor of tissue metalloproteinases Biochem J 1984;218:277-280.
16. Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991;5:2145-2154.
17. Dean DD, Martel-Pelletier J, Pelletier JP, et al. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 1989;84:678-685.
18. Martel-Pelletier J, McCollum R, Fujimoto N, et al. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab Invest 1994;70:807-815.
19. MacNaul KL, Chartrain N, Lark M, et al. Discoordinale expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression. J Biol Chem 1990;265:17238-17245.
20. Glade MJ, Kanwar YS, Hefley TJ. Enzymatic isolation of chondrocytes from immature rabbit articular cartilage and maintenance of phenotypic expression in culture. J Bobe Miner Res 1991;6:217-226.
21. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
22. Reginato AM, Iozzo RV, Jimenez SA. Formation of nodular structures resembling mature articular cartilage in long-term primary cultures of human fetal epiphyseal chondrocytes on a hydrogel substrate. Arthritis Rheum 1994;37:1338-1349.
23. Richardson D, Dodge G. Cloning of equine type II procollagen and the modulation of its expression in cultured equine articular chondrocytes. Matrix Biol 1997;16:59-64.
24. Reynolds JJ, Hembry RM, Meikle MC. Connective tissue degradation in health and periodontal disease and the roles of matrix metalloproteinases and their natural inhibitors. Adv Dent Res 1994;8: 312-319.
25. Van Wart HE, Birkedal-Hansen H. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci U S A 1990;87:5578-5582.
26. Pourmotabbed T, Aelion JA, Tyrrell D, et al. Role of the conserved histidine and aspartic acid residues in activity and stabilization of human gelatinase B: an example of matrix metalloproteinases. J Protein Chem 1995;14:527-535.
27. Springman EB, Angleton EL, Birkedal-Hansen H, et al. Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. Proc Natl Acad Sci U S A 1990;87:364-368.
28. Sanchez-Lopez R, Nicholson R, Gesnel M, et al. Structure-function relationships in the collagenase family member transin. J Biol Chem 1988;263:11892-11899.
29. Hanglow AC. Lugo A, Walsky R, et al. Peptides based on the conserved predomain sequence of matrix metalloproteinases inhibit human stromelysin and collagenase. Agents Actions 1993;39: C148-C150.
30. Park AJ, Matrisian LM, Kells AF, et al. Mutational analysis of the transin (rat stromelysin) autoinhibitor region demonstrates a role for residues surrounding the "cysteine switch". J Biol Chem 1991;266:1584-1590.
31. Nagase H, Suzuki K, Cawston TE, et al. Involvement of a region near valine-69 of tissue inhibitor of metalloproteinases (TIMP)-1 in the interaction with matrix metalloproteinase 3 (stromelysin 1). Biochem J 1997;325:163-167.